No, not a Tesla, but something even more wonderful: It appears that not too far down the road there may be a right-off-the-showroom-floor, off-the-shelf T-cell gene therapy which will be extremely effective, more readily available, and much less costly. That’s the new CAR I’m wishing for. To learn more about CAR, T-cell based gene therapy, and the promising news about them, view Andrew Schorr’s recent PatientPower interview, Understanding Advances in Gene Therapy.
Could a blood cancer patient’s own immune cells soon be used to fight their cancer? In chimeric antigen receptor (CAR) gene therapy, T-cells are taken from a patient and genetically engineered to target and destroy cancer cells. Dr. Laurence Cooper, from MD Anderson Cancer Center, explains exciting research that led to deep remission in some cancer patients, including children and those with advanced disease and limited treatment options. Dr. Cooper shares his enthusiasm about the benefits of precision therapy and the goals of creating accessible–and affordable–personalized medicine.
— Patient Power, December 18, 2013
If you yearn for more information about CAR and T-cell gene therapy, read the AP report, Gene therapy scores big wins against blood cancers, and consider exploring the following from the National Cancer Institute and from the recent 2013 American Society of Hematology (ASH) Annual Meeting: